GRIFFITH MELINDA
SEC CIK 1783697 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IMDX | Insight Molecular Diagnostics Inc. | Dir | 30.0K | $10.0K | — | 3 | 2022-06-24 | 2022-08-16 |
Most active insiders at IMDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bradsher Neal C | 10% | $3.00M | — |
| 2 | BROADWOOD PARTNERS, L.P. | 10% | $2.69M | — |
| 3 | James Andrea S. | CFO | — | — |
| 4 | Riggs Josh | CEO, Pres, Dir | — | — |
| 5 | Liu James Yang | VP ACCT, Cntlr, Treas, PAO | — | — |
| 6 | Last Andrew J. | Dir | — | — |
| 7 | Arno Andrew | Dir | — | — |
| 8 | SILVERMAN LOU | Dir | — | — |
GRIFFITH MELINDA made no open-market trades at IMDX in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-17 | 2022-08-16 | IMDX | Insight Molecular Diagnostics Inc. | GRIFFITH MELINDA | Dir | P - Purchase | $1.00 | +10.0K | 30.0K | +50% | +$10.0K |
| D | 2022-08-17 | 2022-08-15 | IMDX | Insight Molecular Diagnostics Inc. | GRIFFITH MELINDA | Dir | A - Grant | $0.00 | +10.0K | 20.0K | +100% | $0 |
| D | 2022-07-19 | 2022-06-24 | IMDX | Insight Molecular Diagnostics Inc. | GRIFFITH MELINDA | Dir | M - OptEx | $0.00 | +10.0K | 10.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations